hg_84439.1

Basic information about the TSS

---

TSS ID: hg_84439.1 Species: human Chr: chr7		Start: 76358948 End: 76358967 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK295029 Distance: 0 GeneID: 7532 HGNC/MGI_ID: HGNC:12852 UniProt_ID: B4DHC4

Gene_name: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma Gene_symbol: YWHAG Gene_synonyms: 14-3-3GAMMA 14-3-3γ PPP1R170 Gene_source: HGNC:12852

TATA-Box annotation

---

Distance to TSS:	33
Nearest PromoterID:	NM_012479
Entrez ID:	7532
Nearest Unigene:	Hs.744840
Nearest Refseq:	NM_012479
Nearest Ensembl:	ENSG00000170027
Gene Name:	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
Gene Alias:	14-3-3GAMMA|EIEE56|PPP1R170
Gene Description:	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.746269
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YWHAG p2@YWHAG p3@YWHAG
Sample		p1@YWHAG	p2@YWHAG	p3@YWHAG
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	72.86	16.36	5.06
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	83.76	17.80	6.88
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	74.85	18.90	5.02
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	66.12	10.81	5.61
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	71.54	16.42	4.27
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	77.52	15.31	4.46
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	78.22	20.26	7.41
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	64.67	15.99	4.60
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	67.96	19.66	4.06
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	79.99	22.61	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	76.40	21.02	6.87
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	77.65	23.58	7.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	43.52	9.51	6.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	42.25	6.92	5.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	44.35	10.98	5.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	43.51	10.06	7.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	40.19	7.43	6.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.42	9.28	8.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	46.92	6.93	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	38.81	7.22	4.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	52.26	8.69	7.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	47.99	8.11	7.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	53.51	8.66	7.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	46.59	8.01	6.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	60.89	10.06	10.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	56.66	11.08	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	56.04	5.49	7.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	71.90	10.37	10.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	57.83	7.27	7.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	68.40	11.94	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	63.43	6.91	8.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	69.36	11.92	9.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	64.57	11.18	9.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	51.13	10.72	6.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	65.26	12.34	10.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	77.03	10.54	8.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	54.98	9.40	9.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	66.69	13.50	12.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	87.24	14.32	8.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	71.30	7.92	8.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	68.93	11.06	8.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	56.22	11.86	10.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	65.38	9.70	8.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	59.97	10.66	9.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	67.46	10.84	10.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	61.42	11.63	9.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	72.93	7.44	11.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	57.23	12.22	9.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	63.91	12.45	9.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	45.90	8.90	8.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	41.20	10.04	8.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.14	9.78	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	41.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	69.20	13.13	8.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	54.35	13.59	10.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	36.07	12.58	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	26.18	4.59	10.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	40.84	12.96	12.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	53.96	13.81	8.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	27.03	11.94	6.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	48.65	13.40	9.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	50.47	10.65	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.11	8.76	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	20.39	5.44	3.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	39.97	11.37	5.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	52.89	12.07	8.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	56.55	14.14	10.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	61.49	18.35	9.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	53.01	12.20	12.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	29.48	10.27	5.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	54.13	11.75	9.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	64.51	12.23	8.87
Adipocyte - breast, donor1	11376-118A8	68.26	12.20	19.80
Adipocyte - breast, donor2	11327-117E4	107.00	22.14	13.15
Adipocyte - omental, donor1	11473-119C6	85.88	18.07	16.92
Adipocyte - omental, donor2	11474-119C7	71.01	16.44	2.99
Adipocyte - omental, donor3	11475-119C8	67.32	17.42	9.04
Adipocyte - perirenal, donor1	11476-119C9	49.76	14.67	8.29
Adipocyte - subcutaneous, donor1	11259-116F8	42.88	13.19	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	43.36	16.26	10.39
Adipocyte - subcutaneous, donor3	11408-118E4	83.06	18.42	7.82
Adipocyte differentiation, day04, donor1	13019-139D4	99.35	15.06	15.65
Adipocyte differentiation, day04, donor2	13022-139D7	41.44	16.73	10.30
Adipocyte differentiation, day04, donor3	13025-139E1	55.75	14.22	12.27
Adipocyte differentiation, day04, donor4	13028-139E4	73.48	19.40	17.63
Adipocyte differentiation, day08, donor1	13020-139D5	271.22	31.29	21.07
Adipocyte differentiation, day08, donor2	13023-139D8	71.01	16.14	8.71
Adipocyte differentiation, day08, donor3	13026-139E2	95.44	18.13	10.66
Adipocyte differentiation, day08, donor4	13029-139E5	155.80	25.04	13.91
Adipocyte differentiation, day12, donor1	13021-139D6	172.18	29.11	17.88
Adipocyte differentiation, day12, donor2	13024-139D9	92.93	18.59	13.31
Adipocyte differentiation, day12, donor3	13027-139E3	112.25	23.56	16.69
Adipocyte differentiation, day12, donor4	13030-139E6	142.19	25.27	17.05
Alveolar Epithelial Cells, donor1	11510-119G7	89.50	30.28	13.48
Alveolar Epithelial Cells, donor2	11590-120G6	29.40	8.25	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	7.19	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	59.01	16.19	10.43
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	15.06	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	52.59	14.59	11.09
Anulus Pulposus Cell, donor1	11248-116E6	34.21	13.96	8.93
Anulus Pulposus Cell, donor2	11463-119B5	33.80	16.65	6.37
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.25	14.83	5.84
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	39.51	10.85	6.95
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	21.40	8.56
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.57	14.05	9.57
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	15.18	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	46.86	6.60	11.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	34.44	9.75	8.45
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	36.89	11.17	10.68
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.23	13.07	9.50
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	34.65	11.68	7.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	31.20	7.98	7.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	32.60	5.02	12.54
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	48.93	11.04	11.20
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	24.57	15.01	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	37.55	9.80	11.16
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	47.15	12.32	11.79
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	51.20	10.77	13.23
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	44.64	14.43	14.70
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	35.12	9.75	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	40.47	9.29	8.96
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	34.82	6.00	10.81
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	10.62	10.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	36.88	9.26	10.12
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	33.01	10.19	5.83
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	41.74	8.35	14.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	36.34	4.85	13.33
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	29.07	10.26	8.55
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	42.11	9.41	8.98
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	32.52	10.07	9.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	33.31	10.32	7.04
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	38.59	12.22	7.07
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.82	12.84	8.56
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	32.17	11.70	7.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	43.66	14.15	8.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	34.45	11.88	10.69
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	34.07	9.66	8.14
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.07	9.93	8.91
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	32.40	10.80	9.53
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	30.64	14.67	8.20
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	44.67	8.04	10.80
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	36.83	13.63	10.73
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	31.18	10.39	4.72
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	39.16	10.34	8.98
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	2.32	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	27.46	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	43.53	9.65	8.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	34.90	9.63	9.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	40.82	13.12	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	36.78	8.74	10.11
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	17.85	12.75
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	37.63	11.19	11.69
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	45.83	11.77	11.56
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	36.41	12.24	9.49
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	34.89	13.86	9.56
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	48.12	9.09	11.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	13.73	10.68
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	44.31	9.97	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	46.34	15.09	11.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	36.71	6.54	11.27
Astrocyte - cerebellum, donor1	11500-119F6	73.20	43.23	10.56
Astrocyte - cerebellum, donor2	11580-120F5	66.92	26.36	9.07
Astrocyte - cerebellum, donor3	11661-122F5	42.58	16.99	9.86
Astrocyte - cerebral cortex, donor1	11235-116D2	60.31	17.43	13.59
Astrocyte - cerebral cortex, donor2	11316-117D2	77.49	24.43	11.16
Astrocyte - cerebral cortex, donor3	11392-118C6	83.98	25.21	14.02
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	76.95	39.57	22.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	86.07	36.21	24.56
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	73.97	38.80	21.28
Basophils, donor1	12241-129G9	12.03	4.71	4.97
Basophils, donor2	12242-129H1	15.87	5.77	6.86
Basophils, donor3	12243-129H2	23.08	3.38	8.53
Bronchial Epithelial Cell, donor1	11511-119G8	59.72	15.52	6.90
Bronchial Epithelial Cell, donor2	11591-120G7	29.72	7.77	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	28.69	14.35
Bronchial Epithelial Cell, donor4	11453-119A4	69.04	15.06	5.02
Bronchial Epithelial Cell, donor5	11457-119A8	83.60	13.31	5.20
Bronchial Epithelial Cell, donor6	11461-119B3	43.52	9.90	3.68
Bronchial Epithelial Cell, donor7	11769-123I5	50.02	16.02	6.66
Burkitt's lymphoma cell line:DAUDI	10422-106C8	103.16	23.81	17.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	103.88	44.25	16.54
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	73.55	18.55	12.47
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	51.71	10.34
CD14+ Monocytes, donor1	11224-116B9	30.43	2.82	12.40
CD14+ Monocytes, donor2	11305-117B9	18.37	5.57	10.02
CD14+ Monocytes, donor3	11381-118B4	24.81	4.83	7.24
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	55.19	16.70	15.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	61.03	22.74	21.23
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.86	15.45	19.40
CD14+ monocytes - mock treated, donor1	11863-125A9	152.79	16.48	17.20
CD14+ monocytes - mock treated, donor2	11873-125C1	148.16	10.26	16.29
CD14+ monocytes - mock treated, donor3	11883-125D2	161.32	16.35	18.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	95.58	11.05	8.87
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	116.20	10.76	16.01
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	110.33	8.18	9.92
CD14+ monocytes - treated with BCG, donor1	11860-125A6	75.38	6.07	9.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	89.74	7.83	12.46
CD14+ monocytes - treated with BCG, donor3	11880-125C8	74.86	7.62	7.40
CD14+ monocytes - treated with Candida, donor1	11868-125B5	42.14	3.51	3.28
CD14+ monocytes - treated with Candida, donor2	11878-125C6	60.20	11.62	10.56
CD14+ monocytes - treated with Candida, donor3	11888-125D7	43.26	6.66	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	110.22	11.60	10.41
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	134.50	11.37	12.57
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	99.52	10.83	8.74
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	78.70	7.78	11.90
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	72.16	9.05	9.95
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	72.02	8.29	5.67
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	102.75	10.22	15.60
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	110.26	11.86	20.94
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	122.04	15.57	17.67
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	54.93	4.59	4.23
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	86.66	7.05	5.99
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	78.53	5.70	8.34
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	85.62	7.50	9.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	73.22	7.81	13.01
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	75.23	6.90	9.92
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	51.60	6.96	5.73
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	39.17	5.33	5.79
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	45.01	4.41	5.80
CD14+CD16+ Monocytes, donor1	11789-124B7	27.03	9.59	12.86
CD14+CD16+ Monocytes, donor2	11801-124D1	33.73	9.70	12.94
CD14+CD16+ Monocytes, donor3	11912-125G4	22.09	6.93	10.40
CD14+CD16- Monocytes, donor1	11788-124B6	61.20	15.11	20.87
CD14+CD16- Monocytes, donor2	11799-124C8	40.69	14.67	16.24
CD14+CD16- Monocytes, donor3	11910-125G2	42.14	14.72	15.83
CD14-CD16+ Monocytes, donor1	11790-124B8	28.32	6.12	10.21
CD14-CD16+ Monocytes, donor2	11800-124C9	31.62	8.12	7.25
CD14-CD16+ Monocytes, donor3	11911-125G3	26.32	7.16	7.37
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	2.03	14.23
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	9.49	13.56
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	20.71	9.32	12.43
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	39.44	3.20	14.39
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	9.65	12.87
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.89	3.51	7.72
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	21.96	6.27	4.71
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	9.23	15.82
CD19+ B Cells, donor1	11544-120B5	35.34	8.22	12.33
CD19+ B Cells, donor2	11624-122B4	30.47	8.71	10.16
CD19+ B Cells, donor3	11705-123B4	28.78	8.58	10.60
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	47.27	16.57	11.31
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	35.16	11.59	7.19
CD34+ Progenitors, donor1	11545-120B6	41.17	14.06	6.02
CD34+ Progenitors, donor2	11625-122B5	50.00	13.48	6.18
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	74.78	20.29	9.39
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	65.62	26.38	15.11
CD4+ T Cells, donor1	11225-116C1	39.63	13.93	13.21
CD4+ T Cells, donor2	11306-117C1	32.46	11.63	5.51
CD4+ T Cells, donor3	11382-118B5	30.50	9.45	9.76
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	24.76	11.49	22.72
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	29.87	13.03	22.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	33.06	10.92	20.41
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	22.28	17.07	14.22
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	30.90	10.53	8.43
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	16.48	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	22.11	12.72	20.81
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	38.81	16.61	31.35
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.31	12.57	24.66
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	17.48	4.93	5.38
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.26	11.88	11.18
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	17.16	10.12	10.56
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.55	14.76	24.03
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	22.65	12.67	21.82
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	23.72	12.70	21.05
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	27.74	14.14	9.79
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	25.19	26.26	7.50
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	26.90	8.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	28.74	13.17	21.51
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.56	9.96	16.90
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	19.96	8.20	15.76
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	25.79	10.11	6.57
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	25.13	9.53	9.96
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	19.18	11.77	7.41
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	23.26	13.86	13.86
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	26.77	8.31	12.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	22.33	6.98	11.17
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	27.42	13.29	6.37
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	21.84	13.01	10.06
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	20.02	15.40	13.86
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	23.64	9.67	11.10
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	18.00	12.46	15.23
CD8+ T Cells, donor1	11226-116C2	28.81	5.89	7.53
CD8+ T Cells, donor2	11307-117C2	27.41	2.63	7.13
CD8+ T Cells, donor3	11383-118B6	29.29	9.85	8.84
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	63.77	19.04	20.87
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	49.13	20.13	18.45
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	57.45	20.52	31.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	69.05	18.61	21.62
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	56.16	19.44	27.12
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	48.89	23.42	19.33
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	57.15	12.39	20.21
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	65.01	14.74	21.06
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	65.20	14.07	18.53
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	55.85	13.58	15.09
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	50.84	17.14	19.75
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	57.02	15.99	17.32
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	67.41	17.95	11.82
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	71.96	12.75	13.21
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	84.28	20.14	15.66
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	61.95	20.17	21.97
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	48.91	19.57	20.14
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	66.00	20.27	24.75
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	71.94	20.28	23.45
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	81.20	18.45	18.76
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	69.57	24.68	21.80
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	64.64	14.53	16.83
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	57.54	20.49	15.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	48.41	13.62	10.59
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	84.31	14.45	18.47
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	88.83	10.49	20.98
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	84.15	13.02	12.02
Cardiac Myocyte, donor1	11525-119I4	56.66	25.59	18.28
Cardiac Myocyte, donor2	11605-120I3	42.99	12.85	9.88
Cardiac Myocyte, donor3	11686-122I3	69.66	11.79	8.52
Chondrocyte - de diff, donor1	11261-116G1	40.56	11.44	12.83
Chondrocyte - de diff, donor2	11338-117F6	39.45	12.79	14.93
Chondrocyte - de diff, donor3	11410-118E6	38.57	8.42	11.15
Chondrocyte - re diff, donor2	11339-117F7	90.42	36.71	31.33
Chondrocyte - re diff, donor3	11411-118E7	44.08	11.73	12.54
Ciliary Epithelial Cells, donor1	11242-116D9	65.30	28.57	20.20
Ciliary Epithelial Cells, donor2	11323-117D9	63.06	24.58	19.67
Ciliary Epithelial Cells, donor3	11399-118D4	70.98	24.51	18.14
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	90.69	56.12	34.57
Corneal Epithelial Cells, donor1	11526-119I5	52.04	14.93	5.49
Corneal Epithelial Cells, donor2	11606-120I4	45.50	26.16	6.83
Corneal Epithelial Cells, donor3	11687-122I4	60.33	20.45	9.20
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	90.47	23.94	29.72
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	91.78	20.50	25.86
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	27.61	44.86
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	80.45	19.44	20.95
Dendritic Cells - plasmacytoid, donor1	11228-116C4	42.71	6.49	9.91
Dendritic Cells - plasmacytoid, donor2	11309-117C4	31.99	5.22	11.75
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.20	6.29	4.36
Endothelial Cells - Aortic, donor0	11207-116A1	102.23	11.01	12.51
Endothelial Cells - Aortic, donor1	11263-116G3	93.30	9.39	4.11
Endothelial Cells - Aortic, donor2	11340-117F8	103.50	14.14	12.16
Endothelial Cells - Aortic, donor3	11412-118E8	119.92	19.27	21.63
Endothelial Cells - Artery, donor1	11264-116G4	55.56	6.69	6.40
Endothelial Cells - Artery, donor2	11341-117F9	81.64	11.29	11.76
Endothelial Cells - Artery, donor3	11413-118E9	90.46	12.10	14.02
Endothelial Cells - Lymphatic, donor1	11236-116D3	74.70	9.53	12.63
Endothelial Cells - Lymphatic, donor2	11317-117D3	87.63	14.60	16.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	94.16	11.56	12.40
Endothelial Cells - Microvascular, donor1	11265-116G5	55.27	12.48	6.24
Endothelial Cells - Microvascular, donor2	11342-117G1	66.65	12.50	10.93
Endothelial Cells - Microvascular, donor3	11414-118F1	60.54	6.95	9.78
Endothelial Cells - Thoracic, donor1	11266-116G6	93.23	14.40	10.40
Endothelial Cells - Thoracic, donor2	11343-117G2	53.46	8.91	9.43
Endothelial Cells - Umbilical vein, donor1	11243-116E1	94.18	17.64	13.67
Endothelial Cells - Umbilical vein, donor2	11324-117E1	66.48	13.47	11.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	101.85	13.31	11.97
Endothelial Cells - Vein, donor1	11267-116G7	60.29	7.96	9.10
Endothelial Cells - Vein, donor2	11344-117G3	64.96	9.08	11.18
Endothelial Cells - Vein, donor3	11416-118F3	97.50	8.16	12.56
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	42.91	8.25	3.30
Eosinophils, donor3	12246-129H5	39.24	21.40	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	60.35	19.06	5.62
Esophageal Epithelial Cells, donor2	11587-120G3	64.49	10.40	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	32.54
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	58.70	10.26	20.94
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	38.43	7.12	8.54
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	44.64	7.91	10.40
Fibroblast - Aortic Adventitial, donor1	11245-116E3	67.67	13.70	15.40
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	76.15	15.83	16.65
Fibroblast - Aortic Adventitial, donor2	11326-117E3	57.69	11.50	14.77
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	51.64	17.13	7.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	66.11	15.61	12.62
Fibroblast - Cardiac, donor1	11268-116G8	79.84	18.15	18.15
Fibroblast - Cardiac, donor2	11345-117G4	103.84	14.40	15.16
Fibroblast - Cardiac, donor3	11417-118F4	45.90	7.57	11.20
Fibroblast - Cardiac, donor4	11452-119A3	63.96	21.52	16.37
Fibroblast - Cardiac, donor5	11456-119A7	74.87	14.72	10.91
Fibroblast - Cardiac, donor6	11460-119B2	70.04	14.25	9.10
Fibroblast - Choroid Plexus, donor1	11492-119E7	79.99	23.85	5.76
Fibroblast - Choroid Plexus, donor2	11572-120E6	54.36	15.96	21.57
Fibroblast - Choroid Plexus, donor3	11653-122E6	61.52	24.90	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	90.41	25.60	17.76
Fibroblast - Conjunctival, donor3	11692-122I9	32.73	12.21	7.97
Fibroblast - Dermal, donor1	11269-116G9	35.69	13.15	9.39
Fibroblast - Dermal, donor2	11346-117G5	43.39	21.70	14.62
Fibroblast - Dermal, donor3	11418-118F5	37.60	8.22	12.81
Fibroblast - Dermal, donor4	11450-119A1	50.64	18.54	9.83
Fibroblast - Dermal, donor5	11454-119A5	70.30	19.54	9.59
Fibroblast - Dermal, donor6	11458-119A9	82.19	19.98	10.40
Fibroblast - Gingival, donor1	11237-116D4	57.05	12.91	13.74
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	50.30	16.51	18.08
Fibroblast - Gingival, donor2	11318-117D4	45.07	12.78	11.73
Fibroblast - Gingival, donor3	11394-118C8	57.24	13.54	14.89
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	48.83	12.47	17.66
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	42.99	9.87	17.62
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	55.34	16.37	18.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	46.38	18.26	18.80
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	35.29	14.47	11.65
Fibroblast - Gingival, donor7 (control)	11924-125H7	44.46	19.01	18.87
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	40.36	16.23	16.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	63.62	18.54	25.45
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.57	11.74	18.93
Fibroblast - Lung, donor1	11270-116H1	32.62	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	46.26	19.40	11.94
Fibroblast - Lung, donor3	11419-118F6	54.03	10.13	18.78
Fibroblast - Lymphatic, donor1	11506-119G3	67.47	35.82	5.83
Fibroblast - Lymphatic, donor2	11586-120G2	72.73	22.38	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	16.23	3.64	2.80
Fibroblast - Mammary, donor1	11540-120B1	109.21	28.82	17.86
Fibroblast - Mammary, donor2	11620-122A9	3.99	7.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	83.39	23.83	11.91
Fibroblast - Periodontal Ligament, donor1	11238-116D5	54.51	14.16	13.38
Fibroblast - Periodontal Ligament, donor2	11319-117D5	71.90	17.90	16.53
Fibroblast - Periodontal Ligament, donor3	11395-118C9	87.82	18.05	23.26
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.40	9.92	9.16
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	54.27	13.77	19.98
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	49.40	10.67	13.34
Fibroblast - Pulmonary Artery, donor1	11250-116E8	73.84	14.15	15.03
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	86.15	22.96	17.27
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.07	16.04	13.36
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	37.16	13.84	3.95
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	45.84	19.84	11.71
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.77	6.22	9.77
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	49.47	11.23	13.60
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	50.54	13.24	8.72
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	47.17	13.93	8.20
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	40.74	16.45	9.62
Fibroblast - skin normal, donor1	11553-120C5	42.82	7.88	11.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	48.72	17.44	15.84
Fibroblast - skin normal, donor2	11561-120D4	54.85	20.19	8.94
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	53.50	25.69	9.67
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	45.07	8.70	17.48
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	33.85	11.97	7.86
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	42.70	16.75	8.54
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	54.54	15.55	9.48
Fibroblast - skin walker warburg, donor1	11554-120C6	66.12	14.34	13.16
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	26.66	6.74	5.33
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	44.32	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	51.42	32.25	24.40
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	108.00	17.51	13.70
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	98.89	18.74	11.71
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	123.92	22.49	14.82
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	85.74	29.09	21.44
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	75.29	28.71	26.16
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	79.30	23.96	14.26
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	68.66	35.02	8.82
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	78.09	28.77	10.96
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	77.67	25.16	11.10
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	66.88	34.36	10.04
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	82.84	33.27	13.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	71.20	20.78	10.61
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	121.11	43.95	15.26
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	126.22	35.96	12.68
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	83.01	32.50	12.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	105.31	29.73	10.78
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	121.82	37.24	15.09
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	80.71	30.29	13.01
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	78.04	19.40	11.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	106.88	27.78	11.21
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	73.00	24.92	11.80
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	61.76	16.55	10.34
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	102.05	25.91	14.94
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	72.61	14.30	8.94
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	74.40	17.74	16.13
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	107.72	28.16	15.95
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	90.27	21.90	17.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	89.18	22.58	14.26
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	74.80	24.08	13.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	109.77	20.91	16.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	80.45	18.55	16.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	73.51	17.76	13.07
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	85.62	17.74	13.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	112.30	26.52	14.18
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	76.38	16.51	15.51
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	66.13	14.33	13.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	112.41	23.00	14.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	78.13	14.91	14.59
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	79.86	21.17	10.90
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	99.78	25.02	16.01
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	74.98	13.60	14.87
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	71.46	18.85	17.03
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	95.44	22.27	15.68
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	61.69	12.30	14.71
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	60.60	18.24	16.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	86.38	20.00	20.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	71.40	17.38	9.89
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	72.68	15.76	18.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	87.05	16.71	18.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	66.14	12.74	11.93
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	66.92	12.54	15.85
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	59.65	14.69	9.43
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	66.45	16.86	8.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	66.88	11.61	16.09
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	54.07	13.11	15.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	109.80	22.62	21.10
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	96.74	38.22	8.76
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	104.16	36.82	12.79
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	153.44	50.33	27.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	96.07	26.91	14.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	97.48	32.21	13.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	106.08	53.50	20.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	14.85	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	75.04	27.46	11.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	59.37	38.51	12.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	92.16	22.60	12.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	70.30	17.25	12.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	62.59	27.59	13.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	23.33	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	64.04	17.90	12.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	62.43	21.24	16.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	66.27	24.33	11.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	59.80	24.81	12.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	64.54	15.62	10.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	60.56	18.79	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	81.90	22.91	9.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	52.98	17.17	7.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	54.21	15.25	11.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	56.75	24.02	13.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	65.82	21.40	16.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	46.90	16.91	12.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	42.70	13.36	7.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	35.45	16.72	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	55.86	17.34	14.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	82.50	18.83	11.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	44.73	14.91	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	56.62	20.76	7.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	59.14	19.92	9.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	58.50	16.79	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	69.00	18.75	13.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	62.16	18.75	8.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	63.74	31.87	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	58.34	21.00	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	61.00	24.58	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	58.49	24.58	10.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	20.89	10.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	35.91	16.98	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	46.79	12.55	13.70
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	46.99	9.15	12.47
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	59.60	11.24	25.86
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.32	11.10	7.29
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.56	10.44	4.60
Hep-2 cells mock treated, biol_rep1	11898-125E8	52.80	15.90	11.49
Hep-2 cells mock treated, biol_rep2	11899-125E9	51.99	16.71	12.15
Hep-2 cells mock treated, biol_rep3	11900-125F1	51.87	17.52	12.51
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.93	15.41	13.12
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	63.61	14.40	12.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	58.34	17.65	10.98
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	51.18	8.97	8.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	41.69	11.15	9.26
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.96	10.57	5.45
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	70.51	13.99	8.39
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	49.77	12.12	12.12
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	10.58	15.86
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	76.19	22.22	11.29
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.23	14.53	8.72
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	46.68	15.91	7.52
Hepatocyte, donor1	11523-119I2	18.16	8.47	20.58
Hepatocyte, donor2	11603-120I1	48.48	10.77	12.93
Hepatocyte, donor3	11684-122I1	41.11	8.59	9.20
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	62.01	23.50	20.89
Intestinal epithelial cells (polarized), donor1	11246-116E4	84.24	11.54	14.51
Iris Pigment Epithelial Cells, donor1	11530-119I9	54.61	17.01	8.51
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	9.55	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	54.17	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	37.38	20.77	8.31
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	20.02	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	59.34	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	12.81	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	55.23	27.61	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	50.02	16.67	8.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	7.26	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	21.18	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	38.80	19.96	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	31.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	53.54	19.53	6.93
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	41.76	18.56	7.73
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	62.67	23.26	6.46
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	49.91	19.32	11.27
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	45.63	24.45	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	36.94	15.95	5.88
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	55.45	20.09	8.04
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	32.31	17.54	9.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	58.53	18.41	8.02
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	56.23	12.70	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	47.35	17.22	8.61
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	8.89	12.70
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	49.29	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	41.45	18.49	8.93
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	47.39	14.58	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	54.27	12.14	10.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	70.99	20.06	15.12
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	42.14	10.54	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	69.15	9.43	12.57
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	69.54	22.25	10.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	24.34	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	55.11	12.97	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	42.72	13.95	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	4.50	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	24.39	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	34.14	17.07	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	15.24	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	22.80	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	41.42	17.49	6.44
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	6.05	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	30.66	10.57	6.34
Keratinocyte - epidermal, donor1	11272-116H3	108.85	29.46	16.97
Keratinocyte - epidermal, donor2	11349-117G8	36.90	13.47	3.51
Keratinocyte - epidermal, donor3	11421-118F8	72.41	11.83	10.79
Keratinocyte - oral, donor1	11251-116E9	96.26	21.34	12.49
Keratocytes, donor1	11527-119I6	100.74	14.44	23.72
Keratocytes, donor2	11607-120I5	35.15	12.89	9.37
Keratocytes, donor3	11688-122I5	59.48	9.48	18.77
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	19.78	2.20
Lens Epithelial Cells, donor1	11529-119I8	88.46	20.50	12.94
Lens Epithelial Cells, donor2	11609-120I7	50.86	15.69	12.69
Lens Epithelial Cells, donor3	11690-122I7	81.43	24.32	17.26
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	60.12	13.64	11.03
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	36.56	10.60	6.98
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	63.91	12.75	10.23
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	39.25	12.91	9.14
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	43.49	11.98	9.45
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	45.50	9.38	9.81
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	38.99	13.95	11.49
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	34.89	7.33	6.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	47.43	11.26	9.29
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	41.14	11.47	6.33
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	49.25	8.92	8.72
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	31.10	8.89	6.85
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	48.43	9.41	6.62
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	41.03	10.02	6.92
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	40.93	9.75	9.48
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	49.89	9.24	10.47
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	30.55	5.30	3.74
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.87	14.64	7.50
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	52.33	12.84	7.57
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	32.22	7.61	4.69
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	38.83	11.70	9.21
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	39.77	7.76	6.30
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	42.28	6.73	7.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	50.41	8.33	9.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	35.25	7.78	11.92
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	38.53	8.38	7.33
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	47.97	11.13	9.47
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	50.21	5.50	11.01
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	42.33	8.65	8.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	42.94	8.80	8.38
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	55.24	11.63	7.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	44.66	8.93	10.25
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	40.64	8.92	7.81
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	49.61	16.66	12.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	36.57	10.13	9.64
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	40.42	10.04	7.56
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	46.32	11.90	11.58
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	57.21	8.83	10.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	47.45	11.06	9.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	60.09	10.67	9.60
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	36.36	5.82	5.33
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	35.32	8.40	6.38
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	57.30	10.74	7.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	62.07	15.03	10.13
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	30.84	6.36	3.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	79.32	14.36	13.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	31.76	6.92	6.92
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	53.70	8.65	5.67
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	11.33	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	40.66	20.71	10.74
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	37.11	14.84	10.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	40.62	18.62	12.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	42.90	12.66	10.55
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	34.56	7.47	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	30.40	15.46	12.37
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	11.89	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	42.52	12.44	8.82
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	45.66	21.52	16.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.02	18.46	9.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	51.89	18.16	15.31
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	38.51	19.00	12.84
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	50.46	18.70	13.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.32	12.66	8.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	51.45	18.34	12.23
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	51.49	17.08	10.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	43.08	18.89	14.36
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	38.04	14.11	12.88
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	60.34	13.86	6.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	50.81	21.03	14.16
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	56.89	28.31	16.54
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	41.21	21.64	10.30
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	60.67	17.13	13.64
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	47.83	21.82	14.35
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	56.99	16.04	12.17
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	61.15	16.97	16.26
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	49.79	30.98	16.96
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	16.12	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	51.04	22.26	14.97
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.29	23.78	14.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	59.07	14.77	13.95
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	57.39	13.56	12.65
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	56.02	25.85	15.80
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.03	9.71	12.70
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	55.74	19.32	19.32
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.09	24.98	12.06
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	53.09	12.84	8.56
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	45.31	20.99	13.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	47.66	19.31	11.46
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	56.17	15.64	9.95
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	49.50	15.12	9.62
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	47.23	15.57	11.81
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.14	13.47	12.12
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	55.93	19.26	13.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	44.19	11.63	8.14
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	50.77	19.04	4.23
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	52.42	16.01	12.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	45.07	21.08	11.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	48.29	21.46	15.33
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	48.34	18.74	15.78
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	35.76	18.82	12.23
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	46.76	14.58	12.07
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	42.36	13.07	11.27
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	30.98	12.05	15.49
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	50.32	16.03	10.69
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	51.62	25.03	12.51
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	39.58	21.11	7.92
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	50.85	21.28	8.82
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.45	21.00	11.81
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.76	29.63	10.62
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.96	17.67	14.13
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	47.83	16.59	16.20
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	57.72	23.29	11.14
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	50.95	21.15	9.61
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	55.66	22.66	11.13
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	58.33	27.95	13.37
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	41.50	20.75	11.76
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.54	17.86	12.92
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	60.42	23.24	16.53
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	56.23	22.37	7.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	63.06	19.65	19.65
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	61.84	27.19	19.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	57.47	25.86	7.47
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	67.88	16.97	23.14
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	76.39	31.83	23.34
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	77.75	26.67	11.92
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	64.07	20.39	15.81
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	83.00	26.62	26.62
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	77.25	21.29	8.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	77.13	23.23	19.98
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	60.88	34.79	20.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	90.89	35.82	11.76
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	77.99	30.71	21.01
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	69.75	28.45	19.27
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	83.58	28.45	15.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	79.78	26.78	15.96
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	75.92	28.38	16.10
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	65.11	20.25	11.49
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	67.26	31.18	18.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	95.92	24.44	20.28
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	87.53	23.87	14.59
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	60.28	16.63	12.47
Macrophage - monocyte derived, donor1	11232-116C8	64.96	14.81	14.36
Macrophage - monocyte derived, donor2	11313-117C8	83.86	24.41	17.43
Macrophage - monocyte derived, donor3	11389-118C3	108.14	28.58	18.61
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	80.72	18.05	9.56
Mallassez-derived cells, donor2	11929-125I3	100.14	20.44	12.20
Mallassez-derived cells, donor3	11930-125I4	89.51	21.96	11.40
Mammary Epithelial Cell, donor1	11273-116H4	77.32	18.83	12.06
Mammary Epithelial Cell, donor2	11350-117G9	72.39	17.08	10.42
Mammary Epithelial Cell, donor3	11422-118F9	50.88	9.48	5.99
Mast cell - stimulated, donor1	11487-119E2	116.61	25.08	22.37
Mast cell, donor1	11563-120D6	42.93	12.54	20.98
Mast cell, donor2	11565-120D8	52.90	26.15	18.13
Mast cell, donor3	11566-120D9	60.56	33.54	22.29
Mast cell, donor4	11567-120E1	64.18	28.01	27.48
Mast cell, expanded and stimulated, donor5	11940-126A5	34.04	18.52	23.73
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	23.35	28.02
Mast cell, expanded, donor5	11939-126A4	37.06	13.88	17.78
Mast cell, expanded, donor8	11941-126A6	28.29	10.04	11.55
Melanocyte - dark, donor1	11502-119F8	59.20	5.87	8.86
Melanocyte - dark, donor2	11582-120F7	45.34	13.50	5.88
Melanocyte - dark, donor3	11663-122F7	48.54	12.89	24.63
Melanocyte - light, donor1	11274-116H5	37.14	10.58	17.40
Melanocyte - light, donor2	11351-117H1	27.98	8.87	6.14
Melanocyte - light, donor3	11423-118G1	48.56	11.27	12.14
Melanocyte, donor1 (MC+1)	12641-134G4	71.12	11.97	15.20
Melanocyte, donor2 (MC+2)	12739-135I3	47.60	15.87	19.09
Melanocyte, donor3 (MC+3)	12837-137B2	41.52	12.86	17.95
Meningeal Cells, donor1	11493-119E8	128.03	44.29	10.55
Meningeal Cells, donor2	11573-120E7	112.24	32.13	12.76
Meningeal Cells, donor3	11654-122E7	89.90	26.73	24.53
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	36.79	16.54	9.98
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	56.35	10.97	17.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	5.26	7.88
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	14.39	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	54.54	12.20	12.20
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	49.55	9.32	12.49
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	27.65	11.56	10.05
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	46.37	23.07	11.21
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	56.26	17.53	10.23
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	38.47	16.98	10.84
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	27.42	14.27	4.99
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	26.39	9.66	4.83
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	65.00	11.58	14.08
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	22.55	3.86	4.15
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	39.70	16.01	5.12
Mesenchymal stem cells - adipose, donor0	11217-116B2	62.74	14.18	13.47
Mesenchymal stem cells - hepatic, donor0	11218-116B3	59.10	14.07	7.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	49.35	16.69	6.53
Mesothelial Cells, donor1	11247-116E5	86.98	16.18	16.71
Mesothelial Cells, donor2	12156-128G5	59.56	12.01	18.02
Mesothelial Cells, donor3	11402-118D7	83.90	15.03	15.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	74.27	18.90	22.96
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	67.97	18.22	12.81
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	63.01	29.45	19.14
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	89.88	24.20	24.20
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	44.01	13.64	14.26
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	43.15	18.88	16.39
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	69.48	32.42	23.16
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	58.31	15.77	15.27
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	51.67	20.95	17.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	38.93	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	49.99	16.05	14.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	53.85	21.78	15.84
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	25.65	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	33.63	3.54	11.50
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	45.97	20.14	11.40
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	67.11	17.11	15.79
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	38.62	14.64	13.58
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	25.78	16.57	10.13
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.64	16.39	11.33
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	53.65	25.15	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	33.62	9.53	10.54
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	37.31	14.02	11.17
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	61.37	22.12	13.82
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	32.93	12.20	6.68
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	46.48	18.30	10.52
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	46.27	13.66	11.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	42.91	9.23	10.94
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.90	15.12	11.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	113.50	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	33.95	8.98	8.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	31.94	14.70	8.62
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	64.62	21.54	16.57
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	38.59	12.77	10.60
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	46.47	22.64	11.76
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	86.14	20.72	7.63
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	36.52	11.05	6.25
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	47.63	19.21	11.61
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	69.93	23.31	10.97
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	44.05	16.52	5.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	12.23	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	72.70	22.77	5.26
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	45.25	17.66	9.93
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	69.80	15.37	13.45
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	67.19	18.84	11.16
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	55.67	13.92	11.13
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	114.91	35.36	26.52
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	88.55	18.80	10.60
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	70.02	19.26	8.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	122.15	28.05	16.69
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	81.64	17.67	13.47
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	76.06	24.11	9.56
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	89.16	16.32	15.15
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	81.45	18.70	10.56
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	67.62	27.55	10.43
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	14.44	21.66
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	75.73	13.85	6.46
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	64.88	23.90	15.37
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	104.05	25.70	10.92
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	58.83	17.88	7.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	55.77	21.88	15.87
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	76.86	18.42	11.43
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	73.66	24.82	8.54
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	81.42	26.04	8.98
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	91.11	20.48	9.89
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	71.03	20.07	7.33
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	77.40	24.32	10.61
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	81.91	25.03	9.48
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	64.21	23.01	11.08
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	80.38	24.33	10.32
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	61.26	18.25	11.08
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	84.09	25.87	15.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	93.99	24.80	14.70
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	68.83	25.55	16.07
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	86.36	21.14	11.32
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	11.30	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	39.21	17.82	10.69
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	63.09	11.83	18.40
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	27.35	10.52	21.04
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	43.89	18.98	18.58
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	55.88	16.76	15.83
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	41.31	10.89	18.78
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	31.96	15.98	12.52
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	49.20	12.10	15.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.26	15.47	11.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	61.19	13.92	15.39
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	14.00	9.33
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.95	12.83	16.57
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	15.46	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	49.49	8.08	11.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.68	12.65	14.76
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	8.17	12.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.26	3.81	3.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	11.34	5.67	8.10
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	9.06	12.08
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	5.71	51.39
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	91.35	16.31	32.62
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	23.76	23.76
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	150.59	12.55	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	78.63	17.88	19.82
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	43.90	14.11	16.72
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	48.06	13.35	8.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	37.56	11.27	10.02
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.99	8.75	9.13
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	65.43	28.73	15.96
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.08	11.56	6.12
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	79.02	22.05	16.54
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	31.39	10.04	7.53
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.52	10.92	9.30
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	33.24	9.46	9.73
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.33	13.46	9.88
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	44.54	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	37.23	11.42	8.93
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.57	6.50	10.83
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	36.50	4.76	9.29
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	31.52	9.47	9.80
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	41.55	8.93	12.39
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	42.97	11.14	7.96
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.61	10.81	12.61
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	15.75	5.58	8.86
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	27.65	7.32	8.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	51.50	10.41	14.99
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	42.19	10.55	15.47
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	25.74	7.82	7.82
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	41.77	9.00	15.42
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.76	5.86	10.35
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	85.97	27.81	22.76
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	58.37	12.48	17.15
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.02	11.85	12.28
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	23.97	4.27	7.83
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	59.67	13.31	13.31
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	18.06	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	44.98	8.66	14.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	52.30	13.98	18.03
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	52.77	16.27	17.46
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	17.64	22.29
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	45.40	10.97	8.32
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	49.86	11.73	11.73
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	38.35	6.97	6.10
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	54.27	7.24	16.28
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	63.50	16.76	10.58
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	46.54	7.31	11.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	64.98	10.42	13.39
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	39.43	9.57	13.78
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.08	9.07	11.49
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	47.08	14.59	14.59
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	70.48	16.94	17.62
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	107.30	30.66	40.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	56.09	12.19	14.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	33.05	8.81	8.50
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.63	4.54	7.26
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	60.92	5.54	16.61
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	40.81	11.34	9.07
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	65.75	10.12	5.06
Myoblast, donor1	11241-116D8	72.30	15.40	15.65
Myoblast, donor2	11322-117D8	59.65	13.23	18.03
Myoblast, donor3	11398-118D3	54.82	19.00	13.45
NK T cell leukemia cell line:KHYG-1	10777-110G3	85.66	22.77	32.98
Natural Killer Cells, donor1	11230-116C6	22.76	5.84	11.38
Natural Killer Cells, donor2	11311-117C6	20.20	6.33	9.95
Natural Killer Cells, donor3	11387-118C1	25.77	5.34	8.10
Neural stem cells, donor1	11275-116H6	94.36	55.17	48.63
Neural stem cells, donor2	11352-117H2	202.19	67.40	53.92
Neurons, donor1	11494-119E9	193.44	75.10	35.27
Neurons, donor2	11574-120E8	187.14	70.45	33.68
Neurons, donor3	11655-122E8	167.72	61.66	38.64
Neutrophils, donor1	11233-116C9	21.34	1.86	1.86
Neutrophils, donor2	11314-117C9	23.19	11.60	2.90
Neutrophils, donor3	11390-118C4	30.54	7.94	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	46.90	16.86	11.99
Nucleus Pulposus Cell, donor2	11409-118E5	23.44	14.00	9.77
Nucleus Pulposus Cell, donor3	11462-119B4	38.10	14.24	6.02
Olfactory epithelial cells, donor1	11933-125I7	33.45	8.40	11.15
Olfactory epithelial cells, donor2	11934-125I8	41.98	10.42	17.37
Olfactory epithelial cells, donor3	11935-125I9	40.41	9.76	14.19
Olfactory epithelial cells, donor4	11936-126A1	51.52	13.73	14.41
Oligodendrocyte - precursors, donor1	11496-119F2	81.25	11.43	7.22
Osteoblast - differentiated, donor1	11276-116H7	52.96	13.40	9.78
Osteoblast - differentiated, donor2	11353-117H3	12.57	8.00	5.72
Osteoblast - differentiated, donor3	11425-118G3	27.31	5.59	6.83
Osteoblast, donor1	11277-116H8	39.67	14.46	13.49
Osteoblast, donor2	11354-117H4	73.74	24.58	18.26
Osteoblast, donor3	11426-118G4	92.60	15.64	21.86
Pancreatic stromal cells, donor1	11249-116E7	40.52	9.60	15.84
Pericytes, donor1	11491-119E6	26.59	10.90	3.34
Pericytes, donor2	11571-120E5	38.03	15.39	5.66
Pericytes, donor3	11652-122E5	75.28	20.75	12.21
Perineurial Cells, donor1	11499-119F5	60.58	11.64	7.01
Perineurial Cells, donor2	11579-120F4	55.48	15.27	9.85
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	35.38	14.98	13.39
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.00	9.30	6.12
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	30.02	7.64	8.93
Placental Epithelial Cells, donor1	11278-116H9	31.81	4.54	5.02
Placental Epithelial Cells, donor2	11355-117H5	21.07	13.31	2.22
Placental Epithelial Cells, donor3	11427-118G5	26.31	6.68	5.50
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	54.43	7.91	6.01
Preadipocyte - breast, donor1	11467-119B9	51.40	15.01	18.20
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	61.22	13.97	14.75
Preadipocyte - breast, donor2	11328-117E5	59.89	18.01	16.44
Preadipocyte - omental, donor1	11468-119C1	80.45	19.71	21.63
Preadipocyte - omental, donor2	11329-117E6	61.54	20.95	19.64
Preadipocyte - omental, donor3	11403-118D8	75.64	21.77	25.36
Preadipocyte - perirenal, donor1	11469-119C2	72.84	15.75	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	57.74	13.21	19.35
Preadipocyte - subcutaneous, donor2	11356-117H6	71.72	26.56	19.48
Preadipocyte - subcutaneous, donor3	11428-118G6	62.49	15.33	21.12
Preadipocyte - visceral, donor1	11280-116I2	70.42	21.89	26.17
Preadipocyte - visceral, donor2	11357-117H7	53.38	23.47	19.33
Preadipocyte - visceral, donor3	11429-118G7	61.23	16.82	15.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	109.07	13.73	14.03
Prostate Epithelial Cells, donor2	11331-117E8	134.87	25.19	17.33
Prostate Epithelial Cells, donor3	11404-118D9	63.50	10.17	7.23
Prostate Stromal Cells, donor1	11254-116F3	72.44	16.17	17.31
Prostate Stromal Cells, donor2	11332-117E9	53.43	13.09	20.62
Prostate Stromal Cells, donor3	11405-118E1	44.53	11.26	11.57
Renal Cortical Epithelial Cells, donor1	11516-119H4	53.29	14.60	5.84
Renal Cortical Epithelial Cells, donor2	11596-120H3	68.20	19.68	9.63
Renal Epithelial Cells, donor1	11517-119H5	41.59	19.27	2.54
Renal Epithelial Cells, donor2	11597-120H4	50.50	17.07	13.52
Renal Epithelial Cells, donor3	11678-122H4	85.43	27.95	12.17
Renal Glomerular Endothelial Cells, donor1	11514-119H2	59.23	10.89	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	80.45	11.32	6.74
Renal Glomerular Endothelial Cells, donor3	11675-122H1	70.82	23.53	16.87
Renal Glomerular Endothelial Cells, donor4	11783-124B1	27.28	2.00	3.33
Renal Mesangial Cells, donor1	11518-119H6	62.73	22.45	8.80
Renal Mesangial Cells, donor2	11598-120H5	57.06	22.57	12.54
Renal Mesangial Cells, donor3	11679-122H5	33.01	8.88	6.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	79.18	22.82	12.35
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	46.39	14.34	6.75
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	66.53	21.98	10.03
Retinal Pigment Epithelial Cells, donor0	11215-116A9	53.67	15.56	5.96
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.14	25.87	8.81
Retinal Pigment Epithelial Cells, donor2	11608-120I6	21.61	10.29	6.17
Retinal Pigment Epithelial Cells, donor3	11689-122I6	45.16	20.83	13.80
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	85.79	14.97	14.70
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	4.47	11.61
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.57	3.30	7.71
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	5.22	8.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	46.94	14.04	8.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	66.53	13.60	17.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	77.97	18.40	21.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	52.10	12.53	12.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	72.96	13.52	16.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	80.66	16.18	18.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	63.80	14.10	10.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	58.85	11.80	17.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	77.23	15.23	17.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	54.94	13.20	8.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	63.64	12.23	17.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	72.36	14.38	15.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	64.04	12.04	12.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	68.01	11.92	21.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	79.11	18.98	28.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	66.09	11.15	11.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	61.03	11.39	17.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	73.52	12.79	18.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	57.24	13.56	10.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	57.18	11.49	14.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	74.17	15.72	16.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	60.17	16.59	12.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	53.84	10.42	13.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	77.10	14.51	14.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	46.94	16.28	8.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	64.68	12.70	16.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	71.79	16.14	17.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	54.33	12.03	14.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	62.60	13.49	20.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	71.44	15.46	19.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	58.95	15.48	12.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	64.54	12.60	22.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	71.91	15.04	23.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	63.10	14.44	12.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	70.92	16.73	20.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	64.35	15.92	22.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	59.82	12.95	11.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	64.07	13.46	16.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	58.37	10.40	19.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	43.00	14.79	7.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.24	16.19	13.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	64.69	14.71	15.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	40.78	10.45	6.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	45.07	10.13	17.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	37.78	8.16	13.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	35.12	11.63	9.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	56.33	11.50	24.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.24	13.39	12.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	38.28	14.77	7.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	42.98	9.95	12.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	41.64	10.48	17.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	30.70	10.04	5.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	41.41	10.03	13.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	51.08	9.62	9.62
Schwann Cells, donor1	11498-119F4	51.91	18.62	5.27
Schwann Cells, donor2	11578-120F3	57.84	10.21	6.80
Schwann Cells, donor3	11659-122F3	42.72	18.40	12.05
Sebocyte, donor1	11220-116B5	148.99	27.94	23.55
Sebocyte, donor2	11301-117B5	82.72	22.06	12.87
Sebocyte, donor3	11378-118B1	56.06	17.52	7.83
Sertoli Cells, donor1	11255-116F4	72.89	1.66	14.91
Sertoli Cells, donor2	11333-117F1	59.31	28.24	5.65
Skeletal Muscle Cells, donor1	11281-116I3	62.64	16.98	21.73
Skeletal Muscle Cells, donor2	11358-117H8	31.08	5.78	1.45
Skeletal Muscle Cells, donor3	11430-118G8	70.23	16.72	13.38
Skeletal Muscle Cells, donor4	11451-119A2	60.01	22.31	5.03
Skeletal Muscle Cells, donor5	11455-119A6	60.20	20.96	6.24
Skeletal Muscle Cells, donor6	11459-119B1	68.79	26.01	12.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	47.38	15.75	9.07
Skeletal Muscle Satellite Cells, donor2	11321-117D7	49.94	18.41	10.84
Skeletal Muscle Satellite Cells, donor3	11397-118D2	89.29	26.89	14.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	76.25	20.81	22.07
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	54.28	13.03	13.75
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	39.90	14.45	8.67
Skin - palm, donor1	10286-104F7	51.04	18.80	10.74
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	68.62	16.87	5.33
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	86.70	32.72	4.91
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	72.96	19.21	6.62
Small Airway Epithelial Cells, donor1	11256-116F5	96.33	16.82	15.43
Small Airway Epithelial Cells, donor2	11334-117F2	87.63	13.78	10.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	130.88	29.60	12.48
Small Airway Epithelial Cells, donor3	11406-118E2	100.28	14.69	11.84
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	54.62	17.28	10.80
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	53.80	19.12	8.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	72.30	12.93	17.05
Smooth Muscle Cells - Aortic, donor1	11283-116I5	99.67	12.60	11.27
Smooth Muscle Cells - Aortic, donor2	11360-117I1	87.03	20.08	16.54
Smooth Muscle Cells - Aortic, donor3	11432-118H1	61.81	13.13	19.31
Smooth Muscle Cells - Bladder, donor1	11519-119H7	33.02	12.01	6.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	78.12	14.77	18.90
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	56.30	15.74	22.83
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	110.36	22.41	13.70
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	52.42	16.61	11.40
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	66.74	18.61	16.24
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	83.00	13.81	10.96
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	49.78	14.64	5.21
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	42.32	13.09	9.74
Smooth Muscle Cells - Carotid, donor1	11285-116I7	49.50	11.62	12.63
Smooth Muscle Cells - Carotid, donor2	11362-117I3	73.45	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	49.59	10.49	7.15
Smooth Muscle Cells - Colonic, donor1	11239-116D6	44.68	9.59	12.09
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.20	10.98	8.39
Smooth Muscle Cells - Colonic, donor3	11396-118D1	56.57	12.18	9.13
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	96.52	19.49	22.74
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	79.76	18.32	8.62
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	89.06	14.35	13.15
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	40.63	12.97	7.51
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.26	9.50	6.13
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	59.48	22.64	20.43
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	66.67	12.52	14.79
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	53.14	19.93	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	75.50	21.72	13.78
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.75	12.65	8.12
Smooth Muscle Cells - Prostate, donor2	11335-117F3	52.09	13.02	13.52
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.02	5.07	7.10
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	74.63	17.64	21.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	39.01	15.00	9.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	506.55	38.77	5.17
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	77.20	22.32	18.60
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	53.01	16.16	10.10
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	68.32	17.86	12.22
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	15.93	8.85
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	66.48	18.49	18.74
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.50	12.61	8.88
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	104.48	18.85	20.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	80.57	12.49	11.98
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	52.27	13.54	9.78
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	36.33	14.81	9.92
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	55.89	10.31	8.71
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.81	5.24	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	98.11	13.21	19.57
Smooth Muscle Cells - Uterine, donor1	11258-116F7	66.06	21.21	10.38
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.16	7.31	7.02
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.02	4.28	6.80
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	37.82	9.52	9.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.13	5.58	8.18
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	37.01	14.37	7.19
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	37.47	12.21	11.36
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	28.75	15.75	8.67
Smooth muscle cells - airway, control, donor1	11966-126D4	21.59	6.86	5.59
Smooth muscle cells - airway, control, donor2	11967-126D5	26.36	8.39	7.19
Smooth muscle cells - airway, control, donor3	11968-126D6	25.92	7.11	8.36
Smooth muscle cells - airway, control, donor4	11969-126D7	26.13	5.04	5.04
Synoviocyte, donor1	11291-117A4	68.51	15.65	24.24
Synoviocyte, donor2	11368-117I9	37.88	9.89	16.26
Synoviocyte, donor3	11440-118H9	34.63	8.49	4.69
Trabecular Meshwork Cells, donor1	11532-120A2	76.47	21.08	11.79
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	3.96	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	34.96	7.41	6.48
Tracheal Epithelial Cells, donor1	11292-117A5	71.47	14.91	9.61
Tracheal Epithelial Cells, donor2	11369-118A1	51.03	11.60	5.80
Tracheal Epithelial Cells, donor3	11441-118I1	57.84	11.45	4.01
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	88.82	13.90	11.56
Urethra, donor2	10319-105A4	50.36	26.98	10.79
Urothelial Cells, donor1	11520-119H8	93.51	21.25	8.24
Urothelial Cells, donor2	11600-120H7	68.10	14.82	8.41
Urothelial Cells, donor3	11681-122H7	46.99	9.40	5.50
Urothelial cells, donor0	11216-116B1	70.88	14.27	6.91
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.93	24.91	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	31.45	21.44	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	28.75	8.21	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	32.71	14.12	12.40
Whole blood (ribopure), donor090325, donation2	12177-128I8	30.79	18.01	6.97
Whole blood (ribopure), donor090612, donation1	12182-129A4	42.69	19.78	6.25
Whole blood (ribopure), donor090612, donation2	12183-129A5	30.29	19.27	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	28.30	9.13	4.56
Wilms' tumor cell line:G-401	10809-111A8	86.23	25.29	17.15
Wilms' tumor cell line:HFWT	10597-108E3	66.00	19.36	22.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	76.25	16.48	7.26
achilles tendon, donor2	10292-104G4	49.60	12.40	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	167.25	40.03	19.89
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	133.27	31.11	18.34
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	134.61	35.02	24.10
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	88.98	29.66	18.23
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	155.72	52.28	34.01
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	71.27	23.69	21.57
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	82.75	27.77	19.60
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	88.13	26.44	14.10
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	105.36	33.49	27.36
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	188.71	48.93	42.32
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	84.27	35.70	20.24
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	15.60	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	106.20	47.87	31.84
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	96.31	40.13	30.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	101.70	47.05	34.78
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	140.36	101.32	82.26
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	123.79	32.49	30.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	58.01	15.65	14.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	70.83	13.23	26.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	94.32	15.77	27.60
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	95.32	19.26	24.55
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	112.93	44.55	19.16
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	66.04	22.01	13.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	83.62	55.75	24.16
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	152.55	65.54	21.47
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	65.42	34.89	23.99
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	24.37	7.50
adenocarcinoma cell line:IM95m	10796-110I4	82.42	16.72	22.61
adipose tissue, adult, pool1	10010-101C1	144.11	25.59	18.46
adipose, donor1	10184-103D4	60.40	28.15	8.80
adipose, donor2	10185-103D5	60.83	56.77	14.19
adipose, donor3	10186-103D6	71.34	25.87	12.25
adipose, donor4	10187-103D7	113.54	23.40	11.27
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	78.59	40.09	18.15
adrenal gland, adult, pool1	10081-102A9	94.58	14.55	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	102.86	37.89	15.34
alveolar cell carcinoma cell line:SW 1573	10708-109H6	75.39	16.79	30.73
amniotic membrane cells, donor1	12235-129G3	75.35	17.39	9.97
amniotic membrane cells, donor2	12236-129G4	52.41	7.78	4.40
amniotic membrane cells, donor3	12237-129G5	43.01	16.79	6.19
amygdala - adult, donor10196	10167-103B5	270.36	337.95	78.26
amygdala, adult, donor10252	10151-102I7	207.03	124.50	47.04
amygdala, newborn, donor10223	10360-105E9	157.19	163.97	53.26
anaplastic carcinoma cell line:8305C	10428-106D5	36.80	5.73	7.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	115.17	28.24	32.65
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	87.18	31.40	19.04
aorta, adult, pool1	10052-101G7	64.53	23.34	17.06
appendix, adult	10189-103D9	66.76	25.62	16.69
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	86.67	30.27	24.76
artery, adult	10190-103E1	145.38	25.82	16.30
astrocytoma cell line:TM-31	10425-106D2	55.63	13.91	17.82
b cell line:RPMI1788	10427-106D4	74.20	24.54	18.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	92.11	15.54	22.20
bile duct carcinoma cell line:HuCCT1	10432-106D9	55.17	6.95	7.94
bile duct carcinoma cell line:TFK-1	10496-107C1	126.71	4.35	15.73
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	64.31	13.42	16.78
bladder, adult, pool1	10011-101C2	61.06	19.56	16.84
blood, adult, pool1	10053-101G8	22.15	8.86	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	20.55	10.28	11.99
bone marrow, adult	10192-103E3	105.95	29.02	12.82
brain, adult, donor1	10084-102B3	290.09	213.21	95.33
brain, adult, pool1	10012-101C3	293.54	209.91	122.38
brain, fetal, pool1	10085-102B4	414.07	299.20	165.63
breast carcinoma cell line:MCF7	10482-107A5	47.24	16.85	11.56
breast carcinoma cell line:MDA-MB-453	10419-106C5	43.81	8.86	12.23
breast, adult, donor1	10080-102A8	115.54	13.26	9.47
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	143.81	47.51	57.93
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	68.65	20.10	20.10
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	50.88	33.84	10.59
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	84.97	21.06	28.57
carcinoid cell line:NCI-H1770	10703-109H1	128.36	34.79	10.81
carcinoid cell line:NCI-H727	10735-110B6	67.27	12.80	11.16
carcinoid cell line:SK-PN-DW	10719-109I8	96.02	30.42	10.77
carcinosarcoma cell line:JHUCS-1	10642-109A3	85.18	47.38	29.55
caudate nucleus - adult, donor10196	10177-103C6	133.55	143.92	23.03
caudate nucleus, adult, donor10252	10164-103B2	185.90	122.48	27.94
caudate nucleus, adult, donor10258	10379-105H1	188.74	218.54	37.44
caudate nucleus, newborn, donor10223	10354-105E3	120.49	126.72	28.93
cerebellum - adult, donor10196	10173-103C2	113.62	116.53	107.79
cerebellum, adult, donor10252	10166-103B4	142.20	53.80	70.89
cerebellum, adult, pool1	10083-102B2	111.76	55.54	68.64
cerebellum, newborn, donor10223	10357-105E6	48.16	28.23	25.74
cerebral meninges, adult	10188-103D8	217.09	213.31	85.22
cerebrospinal fluid, donor2	10294-104G6	73.09	30.70	16.81
cervical cancer cell line:D98-AH2	10552-107I3	90.44	12.22	21.85
cervical cancer cell line:ME-180	10553-107I4	74.74	9.11	7.62
cervix, adult, pool1	10013-101C4	52.29	21.21	16.06
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	64.51	8.22	24.94
chondrosarcoma cell line:SW 1353	10700-109G7	57.48	7.84	13.06
choriocarcinoma cell line:BeWo	10423-106C9	47.60	8.20	10.19
choriocarcinoma cell line:SCH	10785-110H2	68.75	8.62	10.23
choriocarcinoma cell line:T3M-3	10618-108G6	72.34	17.08	8.54
chorionic membrane cells, donor1	12238-129G6	70.66	16.81	7.41
chorionic membrane cells, donor2	12239-129G7	82.13	11.53	11.63
chorionic membrane cells, donor3	12240-129G8	68.14	17.58	9.34
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	39.38	16.16	14.14
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	90.48	23.44	21.90
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	86.80	27.88	18.58
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	97.58	62.15	17.46
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	105.70	50.07	22.49
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	91.42	40.93	16.90
chronic myelogenous leukemia cell line:K562	10454-106G4	103.35	33.57	20.32
chronic myelogenous leukemia cell line:KU812	10409-106B4	90.44	25.54	16.68
clear cell carcinoma cell line:JHOC-5	10638-108I8	50.29	22.86	7.31
clear cell carcinoma cell line:TEN	10636-108I6	82.59	15.10	14.75
colon carcinoma cell line:CACO-2	10513-107D9	58.57	16.47	11.17
colon carcinoma cell line:COLO-320	10420-106C6	103.38	17.10	11.78
colon, adult, donor1	10082-102B1	39.27	7.14	20.23
colon, adult, pool1	10014-101C5	58.05	13.75	16.57
colon, fetal, donor1	10070-101I7	42.02	14.21	12.36
common myeloid progenitor CMP, donor1	12130-128D6	201.67	50.42	73.34
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	92.21	15.72	32.29
cord blood derived cell line:COBL-a 24h infection	10453-106G3	66.41	14.49	28.07
cord blood derived cell line:COBL-a untreated	10449-106F8	67.97	16.92	26.79
corpus callosum, adult, pool1	10042-101F6	128.25	48.09	24.21
cruciate ligament, donor2	10295-104G7	61.60	13.78	6.48
diaphragm, fetal, donor1	10069-101I6	130.02	10.43	16.05
diencephalon, adult	10193-103E4	145.67	136.55	33.36
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	106.54	45.46	25.49
ductal cell carcinoma cell line:KLM-1	10438-106E6	92.06	22.57	16.93
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	118.19	29.85	10.11
ductus deferens, adult	10196-103E7	30.90	16.45	9.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	48.97	12.96	12.96
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	21.33	16.92
dura mater, adult, donor1	10041-101F5	45.18	21.31	17.92
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	61.07	15.77	6.88
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	49.15	22.93	12.18
embryonic pancreas cell line:1B2C6	10604-108F1	77.69	13.57	13.57
embryonic pancreas cell line:1C3D3	10605-108F2	74.47	13.32	22.10
embryonic pancreas cell line:1C3IKEI	10606-108F3	61.13	10.19	19.76
embryonic pancreas cell line:2C6	10603-108E9	65.67	13.13	19.70
endometrial carcinoma cell line:OMC-2	10497-107C2	116.65	39.55	18.10
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	76.30	14.14	22.65
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	59.34	20.74	12.87
epidermoid carcinoma cell line:A431	10426-106D3	77.14	12.45	8.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	115.26	16.83	12.76
epididymis, adult	10197-103E8	43.75	19.47	15.49
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	72.92	24.48	20.76
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	105.78	15.34	20.06
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	104.71	12.06	12.58
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	73.22	8.76	11.32
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	95.23	11.99	13.00
esophagus, adult, pool1	10015-101C6	67.00	18.90	10.72
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	48.84	24.30	32.81
eye - muscle inferior rectus, donor1	10272-104E2	38.63	36.22	4.83
eye - muscle lateral, donor2	10298-104H1	136.77	25.25	16.83
eye - muscle medial, donor2	10299-104H2	132.45	32.74	20.84
eye - muscle superior, donor2	10297-104G9	64.20	17.20	21.78
eye - vitreous humor, donor1	10268-104D7	56.84	26.23	13.12
eye, fetal, donor1	10054-101G9	61.02	30.00	22.12
fibrosarcoma cell line:HT-1080	10758-110E2	67.96	15.26	11.80
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	59.12	17.09	10.68
frontal lobe, adult, pool1	10040-101F4	387.02	282.88	144.21
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	46.24	9.91	7.51
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	41.51	6.49	11.89
gall bladder, adult	10198-103E9	48.77	16.42	19.56
gamma delta positive T cells, donor1	11937-126A2	14.50	12.35	12.35
gamma delta positive T cells, donor2	11938-126A3	17.18	7.84	14.94
gastric adenocarcinoma cell line:MKN1	10614-108G2	129.48	25.77	24.08
gastric adenocarcinoma cell line:MKN45	10612-108F9	78.91	11.99	17.79
gastric cancer cell line:AZ521	10549-107H9	78.04	26.72	18.20
gastric cancer cell line:GSS	10560-108A2	67.73	29.29	10.98
gastrointestinal carcinoma cell line:ECC12	10615-108G3	70.59	10.51	8.91
giant cell carcinoma cell line:LU65	10487-107B1	110.50	13.54	23.75
giant cell carcinoma cell line:Lu99B	10433-106E1	32.61	8.96	6.02
glassy cell carcinoma cell line:HOKUG	10688-109F4	85.55	10.48	9.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	152.31	28.60	35.15
glioblastoma cell line:A172, tech_rep2	10444-106F3	148.44	25.98	26.96
glioblastoma cell line:T98G	10485-107A8	71.74	15.23	31.46
glioma cell line:GI-1	10413-106B8	54.18	4.39	10.25
globus pallidus - adult, donor10196	10175-103C4	96.95	97.67	23.33
globus pallidus, adult, donor10252	10161-103A8	144.50	31.24	14.89
globus pallidus, adult, donor10258	10367-105F7	34.23	12.32	5.48
globus pallidus, newborn, donor10223	10364-105F4	103.39	77.81	16.52
granulocyte macrophage progenitor, donor1	12131-128D7	203.11	61.18	83.20
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	5.23	20.91
granulosa cell tumor cell line:KGN	10624-108H3	38.08	12.48	9.60
hIPS +CCl2, biol_rep1	14383-156B9	56.47	36.73	11.94
hIPS +CCl2, biol_rep2	14384-156C1	53.50	39.32	10.06
hIPS +CCl2, biol_rep3	14385-156C2	72.78	44.44	9.02
hIPS, biol_rep1	14380-156B6	45.99	47.43	17.25
hIPS, biol_rep2	14381-156B7	87.11	36.35	10.97
hIPS, biol_rep3	14382-156B8	118.07	226.21	19.86
hairy cell leukemia cell line:Mo	10712-109I1	80.17	36.78	21.55
heart - mitral valve, adult	10205-103F7	110.62	26.61	20.33
heart - pulmonic valve, adult	10206-103F8	117.93	23.27	21.70
heart - tricuspid valve, adult	10207-103F9	179.02	44.96	16.65
heart, adult, diseased post-infarction, donor1	10050-101G5	93.87	14.28	19.59
heart, adult, diseased, donor1	10051-101G6	129.45	20.01	17.46
heart, adult, pool1	10016-101C7	146.50	15.41	17.48
heart, fetal, pool1	10046-101G1	142.31	29.26	19.30
hepatic mesenchymal tumor cell line:LI90	10778-110G4	84.54	15.12	13.27
hepatoblastoma cell line:HuH-6	10633-108I3	53.51	13.08	9.51
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	82.54	21.44	9.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	84.72	18.69	12.14
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	82.96	23.34	11.22
hepatoma cell line:Li-7	10484-107A7	103.65	7.67	14.35
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.38	15.68	12.06
hippocampus - adult, donor10196	10169-103B7	198.73	228.06	50.16
hippocampus, adult, donor10252	10153-102I9	165.52	79.60	33.68
hippocampus, adult, donor10258	10374-105G5	271.88	289.31	52.28
hippocampus, newborn, donor10223	10363-105F3	166.72	138.52	53.58
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	86.67	21.36	17.09
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	92.88	29.45	14.33
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	91.91	25.64	17.01
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	81.76	33.27	7.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	73.59	36.15	12.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	89.97	41.38	14.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	71.53	31.24	16.64
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	97.37	47.18	20.03
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	83.00	48.38	18.35
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	75.30	28.18	18.23
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	81.32	32.79	22.82
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	83.49	31.65	21.55
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	106.72	26.29	15.80
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	85.49	24.07	11.30
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	48.00	22.69	13.96
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	103.66	45.44	14.89
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	78.06	40.99	15.70
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	35.48	30.99	7.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	100.04	69.33	17.14
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	99.58	81.85	14.10
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	67.03	57.64	11.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	70.22	29.56	19.27
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	63.58	38.03	24.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	58.59	26.90	16.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	99.58	34.73	18.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	93.00	27.96	11.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	98.81	29.40	17.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	77.46	36.26	12.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	72.85	37.69	13.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	79.29	33.29	8.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	75.50	48.61	13.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	59.11	42.51	10.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	54.13	29.50	13.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	67.75	23.78	18.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	64.36	35.59	18.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	65.87	22.18	16.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	97.81	32.12	12.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	76.65	29.41	13.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	92.68	32.20	15.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	81.60	44.31	9.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	94.34	91.09	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	74.46	37.40	14.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	67.32	57.47	14.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	65.14	41.25	12.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	69.39	42.70	11.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	59.67	23.87	13.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	78.68	25.73	19.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	50.92	18.59	12.12
immature langerhans cells, donor1	11904-125F5	36.32	21.07	25.43
immature langerhans cells, donor2	11905-125F6	104.56	27.72	32.48
insula, adult, pool1	10039-101F3	439.19	359.23	174.60
keratoacanthoma cell line:HKA-1	10791-110H8	68.28	12.36	13.98
kidney, adult, pool1	10017-101C8	55.27	14.82	19.52
kidney, fetal, pool1	10045-101F9	70.52	26.53	19.17
large cell lung carcinoma cell line:IA-LM	10509-107D5	68.31	18.60	14.20
large cell lung carcinoma cell line:NCI-H460	10839-111E2	85.85	8.71	13.27
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	46.24	4.77	4.40
left atrium, adult, donor1	10079-102A7	46.31	9.26	14.17
left ventricle, adult, donor1	10078-102A6	79.89	9.10	10.62
leiomyoblastoma cell line:G-402	10721-110A1	97.68	24.35	13.68
leiomyoma cell line:10964C	10569-108B2	32.69	14.01	3.59
leiomyoma cell line:15242A	10570-108B3	48.37	18.48	13.04
leiomyoma cell line:15425	10571-108B4	48.56	13.11	10.93
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	12.70	19.05
lens epithelial cell line:SRA 01/04	10647-109A8	46.00	10.46	7.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	142.14	35.54	24.20
liposarcoma cell line:KMLS-1	10782-110G8	44.05	8.90	8.59
liposarcoma cell line:SW 872	10726-110A6	88.94	18.15	21.81
liver, adult, pool1	10018-101C9	68.07	9.24	16.21
liver, fetal, pool1	10086-102B5	33.87	8.47	6.58
locus coeruleus - adult, donor10196	10182-103D2	257.09	168.14	75.54
locus coeruleus, adult, donor10252	10165-103B3	176.25	81.57	32.11
locus coeruleus, adult, donor10258	10375-105G6	179.72	93.11	40.63
locus coeruleus, newborn, donor10223	10362-105F2	68.56	37.86	29.44
lung adenocarcinoma cell line:A549	10499-107C4	65.18	11.76	10.24
lung adenocarcinoma cell line:PC-14	10408-106B3	114.44	21.37	9.65
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.03	11.07	4.61
lung, adult, pool1	10019-101D1	59.18	18.78	14.65
lung, fetal, donor1	10068-101I5	45.67	42.53	8.85
lung, right lower lobe, adult, donor1	10075-102A3	40.32	11.00	12.37
lymph node, adult, donor1	10077-102A5	39.29	13.25	15.62
lymphangiectasia cell line:DS-1	10727-110A7	54.14	11.62	11.18
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	50.41	17.51	10.56
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	109.58	22.09	16.99
mature adipocyte, donor1	12231-129F8	344.98	55.50	26.64
mature adipocyte, donor2	12232-129F9	339.72	45.24	23.66
mature adipocyte, donor3	12233-129G1	305.57	36.03	20.86
mature adipocyte, donor4	12234-129G2	277.43	33.17	22.64
maxillary sinus tumor cell line:HSQ-89	10414-106B9	74.81	16.44	20.49
medial frontal gyrus - adult, donor10196	10170-103B8	328.26	314.72	102.65
medial frontal gyrus, adult, donor10252	10150-102I6	262.80	170.67	79.08
medial frontal gyrus, adult, donor10258	10368-105F8	149.31	211.26	67.67
medial frontal gyrus, newborn, donor10223	10352-105E1	149.70	207.70	70.80
medial temporal gyrus - adult, donor10196	10183-103D3	317.25	287.05	129.77
medial temporal gyrus, adult, donor10252	10156-103A3	226.44	143.04	70.67
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	88.61	371.77	46.23
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	287.07	387.55	100.48
medial temporal gyrus, newborn, donor10223	10353-105E2	221.10	235.10	97.99
medulla oblongata - adult, donor10196	10174-103C3	81.77	51.92	20.12
medulla oblongata, adult, donor10252	10155-103A2	136.54	48.92	21.36
medulla oblongata, adult, pool1	10038-101F2	229.05	125.54	64.40
medulla oblongata, newborn, donor10223	10361-105F1	95.82	52.08	31.94
medulloblastoma cell line:D283 Med	10838-111E1	102.96	22.81	8.64
medulloblastoma cell line:ONS-76	10759-110E3	109.31	27.39	16.75
melanoma cell line:COLO 679	10514-107E1	41.54	12.51	16.39
melanoma cell line:G-361	10465-106H6	74.38	22.80	30.68
meningioma cell line:HKBMM	10691-109F7	54.99	6.69	7.42
merkel cell carcinoma cell line:MKL-1	10843-111E6	153.32	39.65	33.48
merkel cell carcinoma cell line:MS-1	10844-111E7	177.31	58.58	25.66
mesenchymal precursor cell - adipose, donor1	11747-123G1	47.87	15.34	10.43
mesenchymal precursor cell - adipose, donor2	11748-123G2	35.08	6.54	7.63
mesenchymal precursor cell - adipose, donor3	11749-123G3	24.85	14.49	4.56
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	42.14	7.59	10.25
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	29.27	9.05	5.97
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	37.48	9.72	12.49
mesenchymal precursor cell - cardiac, donor1	11752-123G6	45.31	8.24	5.84
mesenchymal precursor cell - cardiac, donor2	11753-123G7	41.52	8.86	7.25
mesenchymal precursor cell - cardiac, donor3	11754-123G8	44.17	11.54	9.28
mesenchymal precursor cell - cardiac, donor4	11755-123G9	47.13	13.50	8.51
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	73.98	13.23	13.51
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	45.45	8.56	10.87
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	55.35	16.19	12.04
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	61.44	18.50	9.77
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	39.81	11.84	6.33
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	38.82	17.61	14.38
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.86	9.21	6.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	56.31	14.14	10.26
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.93	15.52	5.87
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	48.27	10.46	13.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	62.85	12.78	8.67
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	50.81	11.78	9.94
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	51.22	15.17	11.45
mesenchymal stem cell line:Hu5/E18	10568-108B1	50.94	18.52	15.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.97	7.31	11.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	31.21	13.05	12.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.27	15.97	10.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	38.82	10.78	10.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	25.65	9.65	11.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	30.46	12.86	11.17
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	39.30	11.00	11.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	40.31	7.88	10.19
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	39.22	10.67	10.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	36.37	12.72	9.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	33.41	13.46	15.38
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	37.40	14.67	13.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.14	7.72	11.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.07	11.87	11.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.08	13.75	12.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	21.88	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	15.49	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	33.78	12.34	11.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	29.10	17.46	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.78	13.86	14.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	38.44	12.27	9.81
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	34.60	16.33	11.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	10.49	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	31.79	14.90	9.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	19.07	23.84
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	32.61	11.86	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	13.40	15.84
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.30	15.83	5.70
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	26.90	9.66	7.59
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	4.30	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	17.22	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	33.41	7.33	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	47.67	3.18	7.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	30.07	9.43	5.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	35.85	9.04	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	40.10	8.02	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	59.13	14.19	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	110.42	17.98	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	74.35	19.28	9.64
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	175.16	24.25	13.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	149.16	24.67	11.22
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	146.29	26.71	13.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	179.73	32.24	14.51
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	202.79	45.79	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	174.85	26.61	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	186.31	26.10	24.28
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	189.80	22.59	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	182.03	9.06	12.36
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	89.09	18.06	10.91
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	96.05	18.17	7.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	87.60	15.28	10.19
mesodermal tumor cell line:HIRS-BM	10696-109G3	33.27	11.61	4.64
mesothelioma cell line:ACC-MESO-1	10493-107B7	181.67	22.44	21.50
mesothelioma cell line:ACC-MESO-4	10494-107B8	82.24	18.77	21.08
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	29.92	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	22.91	4.83	4.73
mesothelioma cell line:Mero-25	10850-111F4	36.31	7.72	6.81
mesothelioma cell line:Mero-41	10851-111F5	103.41	25.67	23.23
mesothelioma cell line:Mero-48a	10852-111F6	59.12	19.93	18.38
mesothelioma cell line:Mero-82	10853-111F7	75.69	14.72	11.04
mesothelioma cell line:Mero-83	10854-111F8	34.90	10.04	5.45
mesothelioma cell line:Mero-84	10855-111F9	99.09	26.04	12.64
mesothelioma cell line:Mero-95	10856-111G1	83.23	26.71	18.01
mesothelioma cell line:NCI-H2052	10847-111F1	39.26	9.61	7.79
mesothelioma cell line:NCI-H226	10846-111E9	82.53	17.92	13.57
mesothelioma cell line:NCI-H2452	10848-111F2	60.98	12.81	14.69
mesothelioma cell line:NCI-H28	10845-111E8	49.88	18.58	16.54
mesothelioma cell line:No36	10857-111G2	73.72	18.27	13.37
mesothelioma cell line:ONE58	10858-111G3	82.37	15.17	17.61
migratory langerhans cells, donor1	11901-125F2	42.99	27.64	23.61
migratory langerhans cells, donor2	11902-125F3	70.09	20.52	31.38
migratory langerhans cells, donor3	11903-125F4	41.64	23.87	26.02
mixed mullerian tumor cell line:HTMMT	10689-109F5	91.09	7.18	20.89
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	66.12	14.62	7.63
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	95.37	16.13	13.82
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	51.00	14.84	17.32
myelodysplastic syndrome cell line:SKM-1	10772-110F7	84.63	10.53	29.20
myeloma cell line:PCM6	10474-106I6	116.23	20.56	20.16
myxofibrosarcoma cell line:MFH-ino	10600-108E6	54.79	18.26	9.64
myxofibrosarcoma cell line:NMFH-1	10684-109E9	61.00	17.06	27.66
nasal epithelial cells, donor1, tech_rep1	12226-129F3	68.19	14.37	6.13
nasal epithelial cells, donor1, tech_rep2	12226-129F3	57.58	11.84	6.03
nasal epithelial cells, donor2	12227-129F4	93.29	10.49	4.42
neuroblastoma cell line:CHP-134	10508-107D4	246.17	43.02	36.81
neuroblastoma cell line:NB-1	10539-107G8	130.40	49.39	33.68
neuroblastoma cell line:NBsusSR	10607-108F4	79.51	8.44	11.18
neuroblastoma cell line:NH-12	10555-107I6	177.59	42.12	24.23
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	38.43	15.18	11.62
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	73.17	21.70	11.40
neuroectodermal tumor cell line:TASK1	10774-110F9	97.21	24.15	15.09
neuroepithelioma cell line:SK-N-MC	10728-110A8	78.84	27.97	8.90
neurofibroma cell line:Hs 53.T	10729-110A9	62.02	17.57	16.24
neutrophil PMN, donor1	12133-128D9	44.62	0.00	29.75
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	28.41	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	121.77	39.74	24.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	148.09	24.02	20.81
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	49.37	10.26	15.39
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	64.64	12.61	20.23
nucleus accumbens, adult, pool1	10037-101F1	334.84	267.06	108.55
occipital cortex - adult, donor10196	10172-103C1	222.52	249.31	96.84
occipital cortex, adult, donor10252	10163-103B1	181.68	84.00	50.72
occipital cortex, newborn, donor10223	10355-105E4	280.24	318.45	114.28
occipital lobe, adult, donor1	10076-102A4	461.82	351.35	149.04
occipital lobe, fetal, donor1	10073-102A1	381.90	212.40	106.85
occipital pole, adult, pool1	10036-101E9	367.87	278.07	144.52
olfactory region, adult	10195-103E6	235.57	202.52	97.05
optic nerve, donor1	10277-104E7	112.06	32.02	18.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	134.18	12.64	17.31
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	131.07	27.48	11.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	73.66	15.24	12.87
oral squamous cell carcinoma cell line:SAS	10544-107H4	104.65	30.03	20.45
osteoclastoma cell line:Hs 706.T	10704-109H2	50.56	12.35	12.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	8.41	13.08
osteosarcoma cell line:HS-Os-1	10558-107I9	80.58	14.42	29.69
ovary, adult, pool1	10020-101D2	62.37	20.79	14.06
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	78.64	23.65	11.00
pancreas, adult, donor1	10049-101G4	55.50	15.99	15.99
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.71	6.71	15.65
papillary adenocarcinoma cell line:8505C	10437-106E5	56.22	6.47	10.90
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	94.55	10.43	10.93
paracentral gyrus, adult, pool1	10035-101E8	425.30	309.62	147.90
parietal cortex, adult, donor10258	10373-105G4	113.77	207.72	26.42
parietal lobe - adult, donor10196	10171-103B9	214.43	249.23	76.18
parietal lobe, adult, donor10252	10157-103A4	234.02	175.01	60.43
parietal lobe, adult, pool1	10034-101E7	435.93	292.03	135.97
parietal lobe, fetal, donor1	10072-101I9	231.79	176.51	87.29
parietal lobe, newborn, donor10223	10356-105E5	244.88	268.81	105.05
parotid gland, adult	10199-103F1	43.78	11.10	10.48
penis, adult	10200-103F2	78.96	26.32	17.19
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	63.78	16.92	8.55
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	98.78	16.32	15.01
pineal gland - adult, donor10196	10179-103C8	78.05	38.06	20.00
pineal gland, adult, donor10252	10160-103A7	139.17	31.98	31.39
pineal gland, adult, donor10258	10377-105G8	73.99	43.27	21.95
pituitary gland - adult, donor10196	10180-103C9	54.64	19.22	14.17
pituitary gland, adult, donor10252	10162-103A9	91.73	26.06	25.02
pituitary gland, adult, donor10258	10378-105G9	52.78	17.88	15.32
placenta, adult, pool1	10021-101D3	68.59	16.99	16.02
plasma cell leukemia cell line:ARH-77	10840-111E3	67.67	23.31	14.83
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	66.46	11.52	9.18
pons, adult, pool1	10033-101E6	431.63	266.38	151.91
postcentral gyrus, adult, pool1	10032-101E5	412.51	292.04	147.85
promyelocytes/myelocytes PMC, donor1	12132-128D8	213.32	52.28	35.55
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	82.30	16.61	9.47
prostate cancer cell line:PC-3	10439-106E7	86.58	16.88	14.16
prostate, adult, pool1	10022-101D4	51.15	15.24	12.42
putamen, adult, donor10196	10176-103C5	277.85	302.87	47.21
putamen, adult, donor10252	10152-102I8	109.80	76.47	39.21
putamen, adult, donor10258, tech_rep1	10372-105G3	72.13	173.76	12.02
putamen, adult, donor10258, tech_rep2	10372-105G3	168.65	212.86	23.92
putamen, newborn, donor10223	10365-105F5	63.72	60.72	36.73
rectal cancer cell line:TT1TKB	10469-106I1	38.69	3.49	3.20
rectum, fetal, donor1	10067-101I4	77.90	33.38	16.69
renal cell carcinoma cell line:OS-RC-2	10411-106B6	66.78	18.87	16.54
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	104.38	33.14	7.46
retina, adult, pool1	10030-101E3	74.35	26.54	20.18
retinoblastoma cell line:Y79	10475-106I7	85.99	33.25	20.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	82.99	35.90	14.14
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	200.21	60.18	20.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	4.55	13.64
salivary acinar cells, donor1	11771-123I7	52.28	13.92	8.42
salivary acinar cells, donor2	11772-123I8	53.01	15.83	9.64
salivary acinar cells, donor3	11773-123I9	52.30	9.27	7.28
salivary gland, adult, pool1	10093-102C3	34.32	14.87	7.44
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.05	8.26	17.54
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	40.09	7.17	14.34
seminal vesicle, adult	10201-103F3	29.10	14.28	14.28
serous adenocarcinoma cell line:JHOS-2	10639-108I9	60.25	20.16	14.58
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	61.65	13.59	6.54
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	25.09	18.06
serous cystadenocarcinoma cell line:HTOA	10693-109F9	107.32	21.89	9.81
signet ring carcinoma cell line:Kato III	10436-106E4	75.27	8.62	9.73
signet ring carcinoma cell line:NUGC-4	10483-107A6	74.32	18.58	22.71
skeletal muscle - soleus muscle, donor1	10282-104F3	190.81	50.36	26.25
skeletal muscle, adult, pool1	10023-101D5	216.13	23.99	31.78
skeletal muscle, fetal, donor1	10066-101I3	90.45	34.17	16.08
skin, adult, donor1	10074-102A2	61.07	27.14	13.57
skin, fetal, donor1	10065-101I2	58.07	24.62	14.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	84.38	20.68	19.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	181.87	39.40	43.18
small cell lung carcinoma cell line:DMS 144	10841-111E4	77.48	46.64	18.50
small cell lung carcinoma cell line:LK-2	10541-107H1	103.02	23.41	23.24
small cell lung carcinoma cell line:NCI-H82	10842-111E5	143.64	50.67	5.63
small cell lung carcinoma cell line:WA-hT	10562-108A4	153.20	48.38	40.10
small intestine, adult, pool1	10024-101D6	57.81	12.06	20.07
small intestine, fetal, donor1	10064-101I1	34.89	14.74	9.34
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	88.22	30.77	34.88
smooth muscle, adult, pool1	10048-101G3	51.69	17.06	13.96
somatostatinoma cell line:QGP-1	10781-110G7	161.08	20.64	35.91
spinal cord - adult, donor10196	10181-103D1	112.87	66.53	30.51
spinal cord, adult, donor10252	10159-103A6	98.17	24.05	17.35
spinal cord, adult, donor10258	10369-105F9	38.74	35.97	6.92
spinal cord, fetal, donor1	10056-101H2	196.37	114.04	51.84
spinal cord, newborn, donor10223	10359-105E8	68.88	44.08	19.29
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	73.18	16.28	13.44
spleen, adult, pool1	10025-101D7	54.74	12.45	20.04
spleen, fetal, pool1	10044-101F8	66.66	19.94	14.94
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	82.71	39.02	23.08
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	104.62	17.47	12.34
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	64.65	24.11	17.82
squamous cell carcinoma cell line:T3M-5	10616-108G4	69.19	7.04	5.86
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	128.54	20.37	25.78
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	151.23	23.30	10.59
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	124.81	12.69	15.65
stomach, fetal, donor1	10062-101H8	42.72	20.29	21.36
submaxillary gland, adult	10202-103F4	45.57	13.67	12.53
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	123.38	17.24	8.10
substantia nigra, adult, donor10258	10371-105G2	198.11	215.69	40.35
substantia nigra, newborn, donor10223	10358-105E7	50.17	33.21	16.25
synovial sarcoma cell line:HS-SY-II	10441-106E9	107.75	46.77	27.28
temporal lobe, adult, pool1	10031-101E4	395.71	310.18	147.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	371.09	216.53	99.72
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	321.30	253.17	80.44
tenocyte, donor1	11763-123H8	48.18	16.76	17.80
tenocyte, donor2	11765-123I1	38.91	9.16	9.92
tenocyte, donor3	11768-123I4	46.33	17.42	10.38
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	186.28	47.25	34.50
teratocarcinoma cell line:NCR-G1	10798-110I6	50.87	14.18	8.94
teratocarcinoma cell line:PA-1	10807-111A6	72.22	15.65	8.99
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	81.75	15.11	13.33
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	83.58	25.34	26.47
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	55.95	7.85	8.40
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	58.63	29.96	35.18
testis, adult, pool1	10026-101D8	64.42	27.81	20.62
testis, adult, pool2	10096-102C6	41.95	40.60	21.65
thalamus - adult, donor10196	10168-103B6	158.97	92.73	29.81
thalamus, adult, donor10252	10154-103A1	136.59	38.13	18.60
thalamus, adult, donor10258, tech_rep1	10370-105G1	100.08	278.67	52.35
thalamus, adult, donor10258, tech_rep2	10370-105G1	143.94	94.37	36.89
thalamus, newborn, donor10223	10366-105F6	94.35	117.37	71.34
throat, adult	10209-103G2	95.12	19.97	12.48
throat, fetal, donor1	10061-101H7	45.10	28.95	22.55
thymic carcinoma cell line:Ty-82	10803-111A2	87.84	50.08	18.48
thymus, adult, pool1	10027-101D9	47.52	21.97	12.33
thymus, fetal, pool1	10043-101F7	74.50	20.68	10.60
thyroid carcinoma cell line:KHM-5M	10776-110G2	45.07	12.10	12.90
thyroid carcinoma cell line:TCO-1	10783-110G9	46.10	9.22	10.06
thyroid, adult, pool1	10028-101E1	48.52	14.09	7.93
thyroid, fetal, donor1	10060-101H6	37.44	16.87	7.38
tongue epidermis (fungiform papillae), donor1	10288-104F9	86.23	18.48	18.48
tongue, adult	10203-103F5	96.75	16.28	17.44
tongue, fetal, donor1	10059-101H5	107.98	18.52	20.49
tonsil, adult, pool1	10047-101G2	63.21	18.03	14.83
trachea, adult, pool1	10029-101E2	64.87	16.85	14.89
trachea, fetal, donor1	10058-101H4	62.32	29.24	9.23
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	53.50	14.88	23.03
transitional-cell carcinoma cell line:5637	10418-106C4	117.53	21.58	16.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	93.39	17.71	20.37
tridermal teratoma cell line:HGRT	10694-109G1	26.64	3.81	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	47.49	13.88	24.04
umbilical cord, fetal, donor1	10057-101H3	62.60	12.52	10.43
uterus, adult, pool1	10100-102D1	50.16	32.42	9.56
uterus, fetal, donor1	10055-101H1	65.01	23.55	13.31
vagina, adult	10204-103F6	95.64	21.32	7.75
vein, adult	10191-103E2	88.78	18.19	13.15
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.38	21.10	11.75